An orally active estrogen receptor–related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity
- 1 December 2025
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 393 (1) , 103787
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute on Aging (RF1AG077160)
This publication has 41 references indexed in Scilit:
- Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915European Journal of Medicinal Chemistry, 2023
- Loss of skeletal muscle estrogen-related receptors leads to severe exercise intoleranceMolecular Metabolism, 2023
- Physical exercise in the prevention and treatment of Alzheimer's diseaseJournal of Sport and Health Science, 2020
- Preclinical validation of the micropipette-guided drug administration (MDA) method in the maternal immune activation model of neurodevelopmental disordersBrain, Behavior, and Immunity, 2020
- Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERRβ/γ selective agonist to ERRα/β/γ pan agonistsBioorganic Chemistry, 2020
- Exercise Mimetics: Impact on Health and PerformanceCell Metabolism, 2017
- Adherence to physical activity in an unsupervised setting: Explanatory variables for high attrition rates among fitness center membersJournal of Science and Medicine in Sport, 2016
- Dependence of Hippocampal Function on ERRγ-Regulated Mitochondrial MetabolismCell Metabolism, 2015
- Exercise counteracts declining hippocampal function in aging and Alzheimer's diseaseNeurobiology of Disease, 2013
- Exercise and PGC-1α-Independent Synchronization of Type I Muscle Metabolism and Vasculature by ERRγCell Metabolism, 2011